284 related articles for article (PubMed ID: 7891856)
1. The striatonigral dynorphin pathway of the rat studied with in vivo microdialysis--II. Effects of dopamine D1 and D2 receptor agonists.
You ZB; Herrera-Marschitz M; Nylander I; Goiny M; O'Connor WT; Ungerstedt U; Terenius L
Neuroscience; 1994 Nov; 63(2):427-34. PubMed ID: 7891856
[TBL] [Abstract][Full Text] [Related]
2. The striatonigral dynorphin pathway of the rat studied with in vivo microdialysis--I. Effects of K(+)-depolarization, lesions and peptidase inhibition.
You ZB; Nylander I; Herrera-Marschitz M; O'Connor WT; Goiny M; Terenius L
Neuroscience; 1994 Nov; 63(2):415-25. PubMed ID: 7891855
[TBL] [Abstract][Full Text] [Related]
3. Modulation of neurotransmitter release by cholecystokinin in the neostriatum and substantia nigra of the rat: regional and receptor specificity.
You ZB; Herrera-Marschitz M; Pettersson E; Nylander I; Goiny M; Shou HZ; Kehr J; Godukhin O; Hökfelt T; Terenius L; Ungerstedt U
Neuroscience; 1996 Oct; 74(3):793-804. PubMed ID: 8884775
[TBL] [Abstract][Full Text] [Related]
4. Effect of morphine on dynorphin B and GABA release in the basal ganglia of rats.
You ZB; Herrera-Marschitz M; Nylander I; Goiny M; Kehr J; Ungerstedt U; Terenius L
Brain Res; 1996 Feb; 710(1-2):241-8. PubMed ID: 8963665
[TBL] [Abstract][Full Text] [Related]
5. Functional neuroanatomy of the nigrostriatal and striatonigral pathways as studied with dual probe microdialysis in the awake rat--II. Evidence for striatal N-methyl-D-aspartate receptor regulation of striatonigral GABAergic transmission and motor function.
Morari M; O'Connor WT; Ungerstedt U; Bianchi C; Fuxe K
Neuroscience; 1996 May; 72(1):89-97. PubMed ID: 8730708
[TBL] [Abstract][Full Text] [Related]
6. Interactions of dopaminergic and GABAergic neurotransmission: impact of 6-hydroxydopamine lesions into the substantia nigra of rats.
Hossain MA; Weiner N
J Pharmacol Exp Ther; 1995 Oct; 275(1):237-44. PubMed ID: 7562556
[TBL] [Abstract][Full Text] [Related]
7. Substantia nigra D1 receptors and stimulation of striatal cholinergic interneurons by dopamine: a proposed circuit mechanism.
Abercrombie ED; DeBoer P
J Neurosci; 1997 Nov; 17(21):8498-505. PubMed ID: 9334422
[TBL] [Abstract][Full Text] [Related]
8. The effects of intranigral GABA and dynorphin A injections on striatal dopamine and GABA release: evidence that dopamine provides inhibitory regulation of striatal GABA neurons via D2 receptors.
Reid MS; O'Connor WT; Herrera-Marschitz M; Ungerstedt U
Brain Res; 1990 Jun; 519(1-2):255-60. PubMed ID: 1975763
[TBL] [Abstract][Full Text] [Related]
9. Differential modulation of striatonigral dynorphin and enkephalin by dopamine receptor subtypes.
Jiang HK; McGinty JF; Hong JS
Brain Res; 1990 Jan; 507(1):57-64. PubMed ID: 1967976
[TBL] [Abstract][Full Text] [Related]
10. In vivo evidence for a differential contribution of striatal and nigral D1 and D2 receptors to L-DOPA induced dyskinesia and the accompanying surge of nigral amino acid levels.
Mela F; Marti M; Bido S; Cenci MA; Morari M
Neurobiol Dis; 2012 Jan; 45(1):573-82. PubMed ID: 22001605
[TBL] [Abstract][Full Text] [Related]
11. Biotransformation of L-DOPA to dopamine in the substantia nigra of freely moving rats: effect of dopamine receptor agonists and antagonists.
Sarre S; Vandeneede D; Ebinger G; Michotte Y
J Neurochem; 1998 Apr; 70(4):1730-9. PubMed ID: 9523592
[TBL] [Abstract][Full Text] [Related]
12. Striato-nigral dynorphin and substance P pathways in the rat. I. Biochemical and immunohistochemical studies.
Christensson-Nylander I; Herrera-Marschitz M; Staines W; Hökfelt T; Terenius L; Ungerstedt U; Cuello C; Oertel WH; Goldstein M
Exp Brain Res; 1986; 64(1):169-92. PubMed ID: 2429858
[TBL] [Abstract][Full Text] [Related]
13. D1 agonist-induced excitation of substantia nigra pars reticulata neurons: mediation by D1 receptors on striatonigral terminals via a pertussis toxin-sensitive coupling pathway.
Martin LP; Waszczak BL
J Neurosci; 1994 Jul; 14(7):4494-506. PubMed ID: 7913124
[TBL] [Abstract][Full Text] [Related]
14. Functional neuroanatomy of the nigrostriatal and striatonigral pathways as studied with dual probe microdialysis in the awake rat--I. Effects of perfusion with tetrodotoxin and low-calcium medium.
Morari M; O'Connor WT; Darvelid M; Ungerstedt U; Bianchi C; Fuxe K
Neuroscience; 1996 May; 72(1):79-87. PubMed ID: 8730707
[TBL] [Abstract][Full Text] [Related]
15. Striato-nigral dynorphin and substance P pathways in the rat. II. Functional analysis.
Herrera-Marschitz M; Christensson-Nylander I; Sharp T; Staines W; Reid M; Hökfelt T; Terenius L; Ungerstedt U
Exp Brain Res; 1986; 64(1):193-207. PubMed ID: 2429859
[TBL] [Abstract][Full Text] [Related]
16. Dopamine receptors mediate alterations in striato-nigral dynorphin and substance P pathways.
Nylander I; Terenius LH
Neuropharmacology; 1987 Sep; 26(9):1295-302. PubMed ID: 2444900
[TBL] [Abstract][Full Text] [Related]
17. Effects of AMPA and D1 receptor activation on striatal and nigral GABA efflux.
Byrnes EM; Reilly A; Bruno JP
Synapse; 1997 Jul; 26(3):254-68. PubMed ID: 9183815
[TBL] [Abstract][Full Text] [Related]
18. N-methyl-D-aspartate receptor blockade differentially modifies regional cerebral metabolic responses to D1 and D2 dopamine agonists in rats with a unilateral 6-hydroxydopamine lesion.
Engber TM; Anderson JJ; Boldry RC; Kuo S; Chase TN
Neuroscience; 1993 Jun; 54(4):1051-61. PubMed ID: 8101981
[TBL] [Abstract][Full Text] [Related]
19. Differential effects of chronic dopamine D1 and D2 receptor agonists on rotational behavior and dopamine receptor binding.
Engber TM; Marin C; Susel Z; Chase TN
Eur J Pharmacol; 1993 Jun; 236(3):385-93. PubMed ID: 8102970
[TBL] [Abstract][Full Text] [Related]
20. Muscarinic antagonists in substantia nigra influence the decarboxylation of L-dopa in striatum.
Izurieta-Sánchez P; Sarre S; Ebinger G; Michotte Y
Eur J Pharmacol; 2000 Jul; 399(2-3):151-60. PubMed ID: 10884514
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]